Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Future Positive Capital
Pre-Seed–Series A
4 people
Mohr Davidow Ventures
San MateoSeed–Late Stage$200K – $4M
7 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
4 people
Saba Investments
El PasoSeed–Series A$200K
8 people
Averin Capital
New YorkSeed–Growth
9 people
Bioindustrial Innovation Canada
SarniaSeed–Series A
12 people
Invest Michigan
NorthvillePre-Seed–Series A$100K – $250K
3 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
tecnet equity NÖ Technologiebeteiligungs-Invest GmbH
St. PöltenSeed–Series A$324K – $3.2M
8 people
IDATEN Ventures
TokyoSeed–Series A
2 people
Incubic Management LLC
Los Altos HillsPre-Seed–Series A$100K – $5M
2 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Series A
7 people
Bluesky Equities Ltd.
CalgarySeed–Series A
10 people
DEFTA Partners
San FranciscoSeed–Series A
5 people
2080 Ventures
Seed–Growth$100K – $500K
Centennial Investors
ColumbiaSeed–Series A$150K – $500K
SIDBI Venture Capital
MumbaiSeed–Growth
6 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
4 people
Aditum Bio
OaklandSeries A–Series B
8 people
Go Big Partners
ArianaPre-Seed–Series A
8 people
Recode Ventures
San FranciscoSeed–Series A
8 people
Relia Health
OntarioPre-Seed–Series A
5 people
TruVenturo GmbH
HamburgSeed–Series A
8 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.













































































